BLCO vs DHR · rev $5.10B vs P/E 39, rev $6.26B
Bausch + Lomb Corp (BLCO) versus Danaher Corporation (DHR) — a side-by-side from cached financials, not a winner call.
Bausch + Lomb Corp (BLCO) is a medical instruments & supplies company listed on NYSE.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Latest reported BLCO revenue for 2025-12-31 was $5.10B. Net income was -$360.0M. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. BLCO currently screens at market cap $5.38B.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
BLCO currently screens at market cap $5.38B. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Not investment advice. Open the BLCO and DHR stock pages for the full models.
Not investment advice.